SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SHILPA MEDICARE

BSE: 530549 22 Aug 2025
Healthcare
₹ 849.35
Shilpa Medicare Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SHILPA MEDICARE - Share Price & Details

Market Cap
₹8,381
High /Low
1,003 / 530.0
Stock P/E
65.2
Book Value
₹243.0
Dividend Yield
0.12
ROCE
7.94
ROE
₹4.28
Face Value
1.0
PEG Ratio
3.92
EVEBITDA
₹25.1
Debt
588
CMP / FCF
-151.0
Debt to equity
₹0.25
NP Ann
78.3
High price all time
1,003
Piotroski score
₹7.0
Graham Number
249.0
No. Eq. Shares
9.78
Net CF
₹-4.25
Net profit
111
Price to book value
3.54
Interest Coverage
₹3.43
Low price all time
4.33
Industry PE
32.8
Reserves
₹2,362
Free Cash Flow
₹-83.9

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
SHILPA MEDICARE LTD.1102.23206.97924.332.128,38165.2
MARKSANS PHARMA LTD.3217.44480.563197.341.06814123.2
STRIDES PHARMA SCIENCE LIMITED5003.74133.474986.161.45807321.6

Peer Comparison Chart


About SHILPA MEDICARE

Shilpa Medicare Ltd., with Security Code 530549, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Shilpa Medicare to hold AGM

(15 Aug 2025)
Shilpa Medicare announced that the 38th Annual General Meeting(AGM) of the company will be held on 23 September 2025. More News.
Read more →

Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide

(14 Aug 2025)
Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a billion people affected by...
Read more →

Shilpa Medicare’s NorUDCA Makes History as First Approved NAFLD Therapy Worldwide

(14 Aug 2025)
Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare...
Read more →

Shilpa Medicare Announces 1:1 Bonus Issue After Q1 Profit Triples — Check Record Date

(13 Aug 2025)
Shilpa Medicare Ltd. announced the issue of bonus shares through an exchange filing on Wednesday, with shareholders owning each equity share...
Read more →

Shilpa Pharma Lifesciences fully redeems its outstanding NCDs

(13 Aug 2025)
Shilpa Medicare announced that its wholly-owned material subsidiary, Shilpa Pharma Lifesciences, has fully redeemed its outstanding senior,...
Read more →

Buy, Sell Or Hold: MCX, ABB, Wockhardt, Zydus Life, Shilpa Medicare — Ask Profit

(13 Aug 2025)
Should you hold shares of Shilpa Medicare Ltd? Should you add shares of Zydus Lifesciences Ltd at the current market price?
Read more →

Company Updates